fda warning letters glp-1 september 2025 news September 8, 2025: FDA launches an import alert listing safe GLP-1 manufacturers – Partnership for Safe Medicines

The FDA has warned six online companies for selling compounded retatrutide, an unlicensed weight-loss drug that has gained traction among social media influencers., "All of a sudden, you have

27.64

★★★★☆4.8 (126)

Beyond the Headlines: FDA Warning Letters to GLP-1 Compounders

28.31

★★★★★4.9 (98)

FDA issued 30 warning letters to telehealth companies for false and misleading claims about compounded GLP-1 products. This marks the second round of enforcement action since the agency's September crackdown on misleading

23.34

★★★★★5.0 (157)

Why the FDA Issued 30 Warning Letters to Telehealth Sites Marketing Compounded GLP-1s

25.32

★★★★★4.7 (84)

FDA takes aim at telehealth companies for promoting unofficial weight loss drug dupes

29.38

★★★★★4.9 (203)

Today, the FDA established a “green list” import alert to help stop potentially dangerous GLP-1 active pharmaceutical ingredients from unverified foreign sources from entering the U.S. market. The agency will continue to

20.64

★★★★★5.0 (176)

FDA Warning Letter Breakdown: Sterility Failures, Subpotent GLP-1 Drugs, and a Compounding Pharmacy Operating Without Control

20.23

★★★★★4.8 (132)